Going Concern (unchanged) — Auditor's going-concern opinion persists; accumulated deficit grew to $209.8M from $168.1M.
Material Weakness (unchanged) — Four material weaknesses in internal controls continue from prior year with no remediation disclosed.

NASDAQ: ADTX Aditxt, Inc. 10-K

Aditxt loses Evofem merger, takes $23.8M writedown; Nasdaq equity deficiency threatens delisting

Filed March 31, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 31, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade ADTX commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 10:18 PM